Form 4: HealthEquity EVP & CFO James Lucania Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


James Lucania, EVP & CFO of HealthEquity, Inc., reported the acquisition and disposal of company stock on April 2nd and 3rd, 2025.

Summary

  • On April 2, 2025, James Lucania acquired 19,721 shares of HealthEquity common stock at $0.
  • These shares were related to restricted stock units vesting over time starting April 1, 2026.
  • On April 3, 2025, Lucania disposed of 4,212 shares of common stock at a weighted average price of $83.8779.
  • Following these transactions, Lucania directly owns 91,804 shares of HealthEquity common stock.

Sentiment

Score: 5

Explanation: The document is a neutral report of stock transactions, with no inherent positive or negative sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the change in insider ownership.

Key Dates

DateDescription
04/02/2025James Lucania acquired 19,721 shares of HealthEquity common stock.
04/03/2025James Lucania disposed of 4,212 shares of HealthEquity common stock.
04/04/2025Date of signature for the Form 4 filing.
04/01/202625% of the restricted stock units vest.

Keywords

HealthEquity, HQY, James Lucania, stock transaction, Form 4, EVP & CFO, insider trading

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.